SLC19A1 polymorphism and serum methotrexate in patients with acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is a common pediatric malignancy. Methotrexate is the widely used chemotherapy for ALL. The polymorphism (rs1051296) of SLC19A1 is proposed for its effect on serum methotrexate. To explain this observation, the authors hereby studied the interrelationship between S...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2018-01-01
|
| Cyfres: | Indian Journal of Medical and Paediatric Oncology |
| Pynciau: | |
| Mynediad Ar-lein: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=1;spage=120;epage=121;aulast=Joob |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|